Catch up on all the latest Forbeck news and progress with our 2026 Spring Newsletter!
Forbeck Foundation SPRING 2026 NEWSLETTER • XLII EDITION
CANCER’S LEADING THINKERS. TOGETHER IN ONE ROOM.
Ruby Heart Tribute Wall From 2025 Blue Jean Ball
1 - A Year of Groundbreaking Conversations 4 - 2026 Spring Scholars 4 - Forbeck on the Forefront Podcast 5 - Scholar Retreat Recap 6 - Sentiments Toward Kindness in Science 8 - Recipe for Success 9 - Turning Connection into Progress 10 - Photos and Memories 14 - Benefactors, Sponsors, and Volunteers IN THIS EDITION
A YEAR OF GROUNDBREAKING CONVERSATIONS
From the snowy slopes of Aspen to the historic halls of an Irish castle, 2025 proved to be a landmark year for cancer research collaboration. Thirteen cutting-edge scientific Forbeck Forums brought together the world’s leading researchers, clinicians, and innovators to tackle some of the most pressing challenges in cancer treatment—and the insights gained are already shaping the future of patient care. Cancer is not a single disease, and it doesn’t respond the same way in everyone. The Foundation’s intimate focused gatherings brought together experts who rarely work in the same room, fostering the kind of cross- pollination of ideas that lead to breakthrough discoveries. Each Forum was carefully designed to bridge gaps between disciplines—connecting cancer biologists with immunologists, computer scientists with clinicians, and laboratory researchers with patient advocates.
CONTINUED ON PAGE 2
FORBECKFORUMS.ORG • FORBECKFOUNDATION.ORG
CANCER’S LEADING THINKERS. TOGETHER IN ONE ROOM. A YEAR OF GROUNDBREAKING CONVERSATIONS
UNDERSTANDING CANCER’S DIVERSITY FEBRUARY 27–MARCH 2
The year kicked off with a critical conversation about sex differences in cancer. Why do men and women develop different cancers at different rates? Why do they respond differently to the same treatments? Led by Dr. Defne Bayik and Dr. Amy Moran at the Hilton Denver Inverness, this Forum explored how understanding these differences can lead to more personalized, effective therapies for everyone.
LISTENING TO WHAT TUMORS DON’T SAY MARCH 27–30
Tumors are complex ecosystems. Beyond cancer cells, tumors are filled with supporting actors such as fibroblasts and immune cells that help cancers grow and resist treatment. The Asilomar Forum, chaired by Dr. Sara Zanivan and Dr. Max Mazzone, brought together international experts to decode the hidden conversations between these cells and discover how to disrupt them.
FORBECK TEAM AARON , JAMIE & MARLA
THE POWER PLANT PROBLEM APRIL 3–6 & MAY 15–18
Two separate Forums tackled mitochondria—the tiny powerhouses inside every cell. When these structures malfunction, they can fuel cancer’s growth. One Forum explored fundamental biology “from worms to patients” at Evin’s Mill, while another at Asilomar examined how targeting mitochondria might supercharge immunotherapy. These meetings represent a bet that understanding cellular energy could unlock entirely new treatment strategies. REWRITING THE CANCER PLAYBOOK THROUGHOUT THE YEAR Several Forums challenged how we think about cancer at its most fundamental level: • In May at The Mollie in Aspen, researchers examined how RNA molecules, the messengers between DNA and proteins, influence cancer’s behavior across multiple cancer types including pancreatic, breast, lung, and colorectal cancers. • At Ireland’s Dunboyne Castle in September, experts explored what happens when cancer cells refuse to die, hiding from treatment only to return later in a form that is resistant to therapy. • Another September gathering, at Italy’s Castello Dal Pozzo, focused on how the DNA within cancer cells is constantly changing, with major implications for aggressive forms of the disease like glioblastoma, neuroblastoma, and ovarian cancer. ARTIFICIAL INTELLIGENCE (AI) ENTERS THE LAB OCTOBER 19–22 Perhaps no Forum symbolized the future more than the AI meeting at The Mollie in Aspen. Dr. Peter Winter and Dr. Barbara Engelhardt led groundbreaking discussions on how artificial intelligence is transforming cancer research and drug discovery, potentially compressing years of laboratory work into months of computational analysis.
2
SPRING 2026 • XLII EDITION
ADVANCING PRECISION MEDICINE OCTOBER 5–8 AND OCTOBER 16–19
October saw two additional critical meetings. At Lake Geneva’s Bella Vista resort, Dr. Jay Sarthy and Dr. Laura Banaszynski brought together pediatric and adult cancer experts, biologists, chemists, and drug developers to explore mutations in histone proteins—the structures that are associated with DNA in our cells. Subtle changes in these proteins have been linked to many types of cancer, particularly in children and young adults. New drugs targeting these mutations are now entering clinical trials. At Evin’s Mill in Tennessee, Dr. Kristopher Sarosiek and Dr. Cristina Munoz Pinedo gathered experts to discuss cell death in cancer therapy—understanding why some cancer cells resist dying when treated and how to overcome resistance across pediatric and adult cancers. THE LONG ROAD AFTER TREATMENT OCTOBER 26–29 Thanks to improving treatments, more children are surviving cancer than ever before. But survival raises new questions: What are the long-term effects of treatment? How can we prevent secondary cancers in survivors? Two back-to- back Forums at The Abbey in Lake Geneva, supported by Curing Kids Cancer, focused on these vital questions. Leading researchers including Dr. Greg Armstrong, Dr. Lindsay Morton, Dr. Melissa Hudson, Dr. Lisa Diller, and Dr. Tara Henderson gathered to ensure that childhood cancer survivors can live full, healthy lives. METABOLIC WARFARE AGAINST CANCER NOVEMBER 13–16 The year concluded with a meeting on one of cancer research’s most promising frontiers: immunometabolism. At the W Mexico City, Dr. Navdeep Chandel and Dr. Susan Kaech led discussions on how cancer cells create hostile environments preventing immune cells from attacking them. By understanding and manipulating cellular metabolism, researchers explored ways to “recharge” immune cells and transform immunotherapy from a treatment that works in 20- 30% of cancers into one that may help many more patients—especially those who have tumors that currently resist treatment. A COMMUNITY OF HOPE What made these Forums special wasn’t just the science—it was the people. Early-career researchers learned from established leaders. Clinicians who see patients every day shared insights with laboratory scientists. Ideas that seemed impossible in isolation became achievable when the right minds connected. Each meeting represented hundreds of hours of planning, thousands of miles traveled, and countless conversations. But they also represented something more: a global community united by a single purpose—to understand cancer better and to translate that understanding into functional treatments. The collaborations forged and insights gained in 2025 are already shaping the next generation of cancer research and treatment approaches that will benefit patients for years to come. For more information about future Forums or to learn about sponsorship opportunities, please visit our scientific website FORBECKFORUMS.ORG . Together, we can accelerate the future of cancer care.
3
THE 2026 SPRING FORBECK SCHOLARS
CANCER AND AGING - CONVERGENT AND OPPOSING FORCES
Eric Sun, PhD Stanford University Sponsor: Jim and Jo Ellen Vanek
Claire Han, PhD, DNP, APRN-CNP The James - The Ohio State University Sponsor: Nancy Geldermann
Claire uses AI and clinical data to predict chemotherapy side effects in aging patients with colorectal cancer. Her work integrates biological aging markers and social factors to improve treatment decisions and patient outcomes.
Eric studies the shared biology of aging and cancer using spatial and single-cell genomics. He develops computational tools to measure aging to predict how interventions affect cells and tissues.
CAUSES AND CONSEQUENCES OF CELLULAR PLASTICITY IN CANCER
Rodrigo Romero, PhD Memorial Sloan Kettering Cancer Center Sponsor: Laura Schiavoni and Brian Willard Rodrigo investigates how cancer cells change identity to resist therapy. His work focuses on the retinoblastoma gene (RB1) which has been identified as a master regulator of the cell cycle. Despite its name the gene has been shown to be involved in a variety of different cancers and Rodrigo is studying prostate cancer using single- cell and spatial genomics.
Clint Stalnecker, PhD University of North Carolina at Chapel Hill Sponsor: Celeste Gleeson
The RAS gene codes for another protein involved in regulating cell growth and differentiation and mutations within the gene are found in around 30% of cancers. Clint is studying how RAS-driven cancers adapt to targeted therapies. He uses systems- level signaling analyses to uncover mechanisms of resistance which can lead to new treatment strategies.
FORBECK ON THE FOREFRONT PODCAST • INSIDE THE SCIENCE YOU SUPPORT
When the Forbeck Foundation welcomed Pam Wenc to its Board in spring of 2025, we knew we were gaining a powerhouse. What we did not yet know was how quickly her connections would create new opportunities for the Foundation and for our community. One of those connections was to Ed Mallof, former President of MAN Marketing in Chicago and now retired in Arizona, although retirement has hardly slowed him down. Like so many in the Forbeck community, Ed has chosen to invest his time and expertise in advancing mission- driven work. What began as a simple coffee meeting grew into a meaningful partnership. It reflects something we see again and again at Forbeck, when passionate people come together, progress accelerates. Because of the strength of our community, the partnership with Ed led to the launch of “Forbeck on the Forefront”, a new podcast now available on Apple Podcasts and Spotify. In 15 minutes or less, each episode translates complex cancer research into accessible, engaging conversations. Drawing from interviews with past Forbeck Forum chairs, the podcast offers a behind-the-scenes look at the ideas your generosity helps support. Each episode is carefully reviewed by scientists to ensure clarity and accuracy. IF YOU HAVE EVER WONDERED WHAT HAPPENS INSIDE A FORBECK FORUM, WHAT BREAKTHROUGHS ARE EMERGING, AND WHY SUSTAINED INVESTMENT IN RESEARCH MATTERS, THIS PODCAST IS YOUR INVITATION INSIDE. We hope you will take a few minutes to listen and share these podcasts within your own circles. This is one more way our community can jointly advance understanding and accelerate progress into finding cures for the disease.
PAM AND RAY WENC WITH ED MALLOF (RIGHT)
4
2025 FALL SCHOLAR RETREAT
ALEJANDRO SWEET-CORDERO, MD • CHIEF, DIVISION OF PEDIATRIC ONCOLOGY AT UCSF SCIENTIFIC ADVISORY BOARD MEMBER
The Forbeck Foundation gathered its community of junior scientists, mentors, and cancer research leaders for the annual Fall Scholar Retreat, held October 2–5 at The Abbey Resort in Lake Geneva, Wisconsin. The retreat, a cornerstone of the Foundation’s Scholar Program, brought together an outstanding interdisciplinary group of investigators from institutions across the United States, Europe, and Asia — united by a shared commitment to accelerating progress against cancer. The retreat featured research presentations from sixteen Scholars, each offering a window into their latest work across a wide range of cancer biology topics. Presentations were designed to spark discussion rather than simply report results, with participants encouraged to engage in real-time dialogue — a hallmark of the Forbeck meeting format. Mentors for this year’s retreat included Kristina Cole, MD, PhD (Children’s Hospital of Philadelphia), Scott L. Coven, DO, MPH (Indiana University),
Lucy A. Godley, MD, PhD (Northwestern University), Kimryn Rathmell, MD, PhD (The Ohio State University), Alejandro Sweet- Cordero, MD (University of California, San Francisco), and Andrei Thomas-Tikhonenko, PhD (University of Pennsylvania).
Beyond the science, a rich slate of discussions addressed the broader landscape of a career in cancer research. Participants and mentors engaged in candid conversations about the role of basic versus translational biomedical research, and how both remain essential to meaningful progress in treating the disease. Collaboration — a foundational value of the Forbeck Foundation since its inception — was a recurring theme, with attendees sharing examples of how cross- disciplinary partnerships have reshaped their own research . Equally emphasized was the importance of asking the right questions and learning to identify and pursue problems that can genuinely move the cancer field forward.
Scholars also explored the human dimensions of a research career. Discussions on resilience reminded attendees that setbacks are an inevitable part of scientific research and that perseverance is as important as talent. Mentors encouraged scholars to embrace the idea that there is no single road to success, and that diverse career paths can each lead to meaningful contributions. The value of mentorship — both receiving it and eventually providing it to the next generation — emerged as a theme that resonated deeply across sessions. The group also tackled timely challenges facing the scientific community: how to adapt to the rapid pace of change in both science and academia, how to counter anti-science thinking and engage the public as effective communicators and educators, and how to thoughtfully approach the emergence of artificial intelligence as both a research tool and a force reshaping the scientific enterprise. Advocacy and public engagement were highlighted as responsibilities that scientists at all career stages are increasingly called upon to embrace.
AS ALWAYS, THE RETREAT CONCLUDED WITH THE FOUNDATION’S ANNUAL BLUE JEAN BALL, GIVING SCHOLARS A MEANINGFUL OPPORTUNITY TO CONNECT WITH FAMILIES AFFECTED BY CANCER — A POWERFUL REMINDER OF THE HUMAN STAKES BEHIND EVERY DEVELOPMENTAL PROGRAM.
5
CANCER’S LEADING THINKERS. TOGETHER IN ONE ROOM. SENTIMENTS TOWARD KINDNESS IN SCIENCE
CLARK C. CHEN, MD, PHD DIRECTOR, BRAIN TUMOR PROGRAM AT BROWN HEALTH STORY BY SCIENTIFIC ADVISORY BOARD MEMBERS W. KIMRYN RATHMELL, MD, PHD, MMHC CEO OF THE OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER
As physician-scientists, we have come to appreciate the profound cultural divide between clinical practice and basic science research. Fundamentally, the patient-doctor interaction is built upon human connection, where excellence in clinical care is generally met with gratitude. A well-crafted surgery, a life-altering decision, and compassionate gestures are recognized by both those we serve and from our peers. This feedback loop reinforces empathy and reminds us that medicine, at its core, is a relational practice. Excellence in scientific inquiry, by contrast, is built on rigorous scrutiny and criticism. That rigor is largely implemented through anonymized peer review, a system designed to protect objectivity. At the same time, the system can also foster a tone that feels impersonal, harsh, or even adversarial. When criticism is delivered without names or faces attached, it becomes easier to forget the human effort behind obtaining the data. Over time, this dynamic has made harshness seem like the norm, a pattern we internalize and unintentionally teach to our trainees. The consequences of this culture are not abstract. Harsh or dismissive reviews take a real toll on morale, creativity, and the willingness to take intellectual risks. In an era of dwindling funding, when every submission feels existential, a cutting critique can land not as scientific discourse but as a personal blow. It erodes confidence, narrows ambition, and pushes talented scientists toward safer, smaller questions. Worse yet, many talented individuals simply leave the field altogether. While it can be argued that those who do not enjoy this “scientific” process never truly belong, this argument collapses under even modest scrutiny. Scientific discovery is inherently unpredictable, and history shows that breakthroughs come from every background, and working style. If our culture pushes out anyone, we are shrinking the very pool of talent capable of generating novel insight. “Kindness in science should not be misconstrued as a compromise; it is a catalyst for resilience, innovation, and shared progress.” Yet there is a path forward to build a community that encourages honest, rigorous discussion while remaining both supportive and kind. Scientists are driven by curiosity, and even in a competitive landscape, the desire to expand discovery is stronger than the forces that divide us. Delivering candid, constructive criticism is easier said than done. Unlike leadership or conflict‑management training, there is almost no structured preparation for giving scientific feedback that is rigorous yet not unduly harsh. Given the demands placed upon scientists, the last thing any of us needs is another mandatory training module. Yet the absence of guidance leaves a real gap in how we support one another.
6
SPRING 2026 • XLII EDITION
The flip side of a thoughtful critique is learning how to receive it well, a skill that is rarely acknowledged yet essential to sustaining a healthy scientific discourse. Doing so requires intentional preparation to interpret feedback with nuance, separating substance from tone. Funding agencies and institutional leadership can help shape a culture of kindness in scientific criticism by creating Forums that define and cultivate the skills required to give and interpret feedback. They can support groups that normalize candid discussion and make these practices part of everyday scientific life. Journals and funding agencies play an important role in setting expectations for how feedback should be exchanged, just as they do for other core aspects of scientific inquiry. They can further advance this effort by encouraging and disseminating research on best practices related to peer review. Together, these efforts signal that humane, rigorous critique is not an optional courtesy but a shared professional standard. Scientists and clinicians are, above all, human – driven and curious yet vulnerable to doubts and disillusionment that affect all of us. Building a community like the one fostered within the Forbeck Foundation, one that recognizes this humanity and supports one another, is essential to sustaining the scientific enterprise. By fostering an environment grounded in respect and encouragement, we not only retain talent but also empower the next generation to pursue bold ideas with confidence and purpose.
SCIENTIFIC ADVISORY BOARD
James Amatruda, MD, PhD Children’s Hospital Los Angeles
W. Kimryn Rathmell, MD, PhD, MMHC Ohio State University
CHAIR
John T Kemshead, MD, FRCPath BioMagnetic Solutions
Stephen Chanock, MD National Cancer Institute Clark Chen, MD, PhD Brown University Lucy A Godley, MD, PhD Northwestern University
Edward Stites, MD, PhD Yale University
VICE CHAIR
Alejandro Sweet-Cordero, MD University of California, San Francisco
Kristina Cole, MD, PhD Children’s Hospital of Philadelphia
Kris C Wood, PhD Duke University
Jan Karlseder, PhD The Salk Institute
7
CANCER’S LEADING THINKERS. TOGETHER IN ONE ROOM. THOUGHTS ON OUR RECIPE FOR SUCCESS
LUCY A. GODLEY, MD, PHD • NORTHWESTERN MEDICINE SCIENTIFIC ADVISORY BOARD MEMBER
THE FORBECK FORUMS ARE LEGENDARY WITHIN THE CANCER COMMUNITY. No other cancer meeting is conducted with Forbeck’s intimate nature: 15-20 cancer investigators of all faculty ranks, comprising basic scientists and clinical investigators meet over 2 1/2 days to discuss one current topic in cancer biology from diverse perspectives. They are joined by two Forbeck Scholars, who are about to or have just started their own laboratories and benefit from the networking that happens during mealtimes and fun events. Forbeck Forums have some quirks that we hold dear, because we think that they contribute to the meaningful interactions that occur during the meeting and sustain relationships afterwards. First, attendees are required to attend the entire meeting. Second, presentations are 30-45 minutes long and are given using five slides. This shocks many first-time attendees who are used to giving such talks with the benefit of
30 or more slides. At first, people could not imagine how they could speak for more than half an hour with only five slides. However, once they listen to the first talk and see how people barely make it through three slides, they relax—There are so many interruptions with eager and excited questions that presenters rarely make it through all of their slides. This gave us an idea…
Just when we thought the Forbeck Forums couldn’t be improved, we decided in 2025 to institute a few new “rules” … and we may have hit upon the secret recipe: We did not allow open computers and only TWO slides. We asked people to put away their computers and cell phones to allow them no distractions and to really focus on the presenters. We figured since no presenter ever really makes it to their fifth slide anyway, we would be bold and encourage even fewer slides. We made sure to have a whiteboard and magic markers available and encouraged people to try NO slides at all. Many opted for this style and gave their talk like a “chalk talk” where the presenter talks and draws at the same time.
To our delight, people followed the new rules and were incredibly well engaged in the meetings. Many told us that the Forbeck Forums remain their favorite meetings, precisely because of the style we have adopted. So, have we come up with the perfect recipe? Only time will tell, but we certainly embrace our new format and look forward to the exciting 2026 meeting schedule!
8
SPRING 2026 • XLII EDITION TURNING CONNECTION INTO PROGRESS
JAMIE FORBECK COLLINS FORBECK FOUNDATION EXECUTIVE DIRECTOR
In the spring of 2025, Forbeck Scholar Lisa Sudmeier, MD, PhD, introduced me to Helaine Bader. Helaine’s son, Theo, died at age 17 from leptomeningeal cancer, a form of brain cancer. Like the Forbeck family, Helaine and her family have taken unimaginable loss and transformed it into action. She is determined to raise awareness of leptomeningeal cancer and accelerate progress for every family facing this devastating diagnosis. That determination is now catalyzing scientific collaboration.
Through Lisa’s introduction and Helaine’s perseverance, the Forbeck Foundation and the Leptomeningeal Cancer Foundation will partner to convene a Forum dedicated to advancing understanding and treatment of the disease. Helaine connected with Adrienne Boire, MD, PhD, of Memorial Sloan Kettering Cancer Center, a past participant of the Foundation’s Cellular Reprogramming and Metastatic Disease Forum, and together they submitted a proposal to bring leading experts together to focus on this urgent challenge. The Foundation’s Scientific Advisory Board responded with resoundingly positive feedback, recognizing both the scientific opportunity and the urgency of the moment. “Recent observations, together with advances in liquid biopsy analytics, large-scale multimodal data computational approaches, and increasing prevalence of leptomeningeal metastasis create an unparalleled opportunity for rapid advances in understanding for leptomeningeal cancer.”
ADRIENNE BOIRE, MD, PHD OF MEMORIAL SLOAN KETTERING CANCER CENTER
We believe meaningful progress happens when scientists, non-profit organizations and families work together—each contributing their unique strengths. When interaction meets expertise, momentum follows. The Forum on Leptomeningeal Cancer is in the early planning stages and is anticipated to take place in Beaver Creek, Colorado, in the spring of 2027—where so many transformative scientific conversations have begun. In 2025, our collaboration with Curing Kids Cancer led to a series of impactful Forums addressing the long-term challenges pediatric cancer survivors face, including secondary malignancies and the role of emerging technology in improving care and outcomes. We are already seeing the ripple effects of those conversations, and we look forward to the discoveries that will emerge from this new partnership.
HELAINE BADER, DOUG AND THEO SKINNER
WE ARE ALWAYS GRATEFUL WHEN MEMBERS OF OUR COMMUNITY HELP SPARK THESE CONNECTIONS. MY FATHER WAS ONE OF THE BEST NETWORKERS I HAVE EVER KNOWN, AND CARRYING THAT SPIRIT FORWARD, BUILDING BRIDGES THAT ACCELERATE DISCOVERY, IS ONE OF THE WAYS WE HONOR HIM.
If you know either individuals or organizations who should be part of this work, we would love to hear from you.
LEARN MORE ABOUT THE LEPTOMENINGEAL CANCER FOUNDATION @ LMCANCER.ORG
9
CANCER’S LEADING THINKERS. TOGETHER IN ONE ROOM. 2025 BLUE JEAN BALL
10
SPRING 2026 • XLII EDITION
CELEBRATING OUR 40TH ANNIVERSARY
11
CANCER’S LEADING THINKERS. TOGETHER IN ONE ROOM. GOLF OUTING • MAHJONG
12
SPRING 2026 • XLII EDITION
COMO CRAWL • TASTE OF LG
13
BENEFACTORS, SPONSORS & VOLUNTEERS
Kathryn & Perry Accettura^ Adreani Family Foundation Tony and Debbie Lynn* Jeong Hyun Ahn, PhD° Alben F and Clara G Bates Foundation Celeste Alcock Carolyn Alexander Peter Alfini James Amatruda, MD, PhD° Robert Anderson Nancy Arango* Dana Arcana Aspen Community Foundation Emily Aylesworth Gail Baccetti Steve and Paula Bailey Lea Ballarino Elissa Banker Brown Catie Banks Peg and Alan Barr Lilly Barrett Shauna Basil Jeff and Jan Beardsley Stephen Beers
Kristina Cole, MD, PhD°* Ben Collins Dorcas Collins*+ Jamie Collins Marguerite Compton Michael and Ellen Condron Pippa Cosper, MD, PhD°* Anna Costello Susannah Costello
Mark and Giusseppina Giannelli Mike and Franca Giannelli Drs. Inger and Craig Gibson Kelley Gibson Reed and Robin Gibson*+ Lora Gier Celeste Gleeson* Richard Jr and Connie Gluth Lucy A. Godley, MD, PhD°* Lisa and Brian Gorski+ Grace Gray Lisa Green Emma Unmeron Guilbaud, PhD° Melissa Hahn+ Kristen Hall Craig Halma James Halpin Terry Hamer Dave and Maria Harrison*+ Martha Harrison Amy Hartwell Sandra Hatch Cara Haubner John and Helen Hawkinson Tina Hearne Juliann and Jason Hecksel+ Marilyn Hedberg*
Keri Kopchik Rowena and Rodney Koschkee*+ Marie Kropp Sarah Kutschke Bridgid Kyle Montague and Ann Laffitte Andrew and Lisa Laing Lake Geneva Country Meats^
Frank Landeros Megan Landess Tobey Lannert Curt and Barb Lansbery Roselyn Lanzito Larry and Sue Larkin Arlena Larocca^ Bob and Renee Larson Lucy Leahy
Roberta and John Costion+ Sara Courtneidge, PhD, Dsc° Monica Crabtree Lauren Cuff Mr. and Mrs Andrew Culbertson+ Edward and Robin Culbertson Arvid and Sue Dahlstrom Jen Daniels Joseph R Darnell Mark and Judith Dasilva* Jolan Deeley Linda and Mike Dein Danielle Deleon Dawn DeMarco^ Michelle and David Dermenjian+ Patricia Dietzler Robert and Irene Dinning Jean Divane Jesse Dixon, MD, PhD° Deborah Douglas Trent Douglas+ Richard and Michele Dousman The Dover Foundation Anindya Dutta MD, PhD° Gail and Sam Eckerling*+ Galen and Jill Eckland*+ Sara O. Edwards Selena Egert Jamie Eggleston^ Susan Elder Elkhorn Area Women’s Club, Inc. Linda Ellis Scott Ellison Stephanie Engels Jodi and Mike Essman Ann Evans Jay and Dawn Fairbanks Tim Fanning John and Elizabeth Farley Charles and Lil Drawdy, Sr Terry and Colleen Dunigan Katie Dunlop DJ Dunsker
Jessica Leary Lelan Ledoux Elizabeth Lee Ann Lehman*+ John and Nancy Lehman Staci Leineberg* Patrick Lenon Larry and Barbara Liebovich Ashly Ligouri Jeff and Ellen Liljiberg Suzy Lindblom Salvatore Lio Marybeth Lockwood Martin Loftus Mr. and Mrs. George J. Ludington* Stephanie Lutz Lucy Lyons Catherine Maas Chuck Magowan Cindy Maher Daniel Mahoney Maddie Mainwood Ed Mallof+ Mary Marchese Sherri Mariani Tony Martorano+ Wendy Martorano+ Rosanne and Ted Maschek* Amy Maslan Susan Mathews Christine Matsukes James Mc Donaugh Maureen and Tom McCabe Mark and Liz McCloy Jim and Maryann McCullough Mary McGregor Victoria McHugh McKee Family Foundation Cindy and Ben Mecum^ Michelle Medina Shafik Memon
Robin Behrstock Haley Beierwaltes Koko Bellamy+ Kristine Benker Steven Benker+ Elizabeth Bergstrom Semir Beyaz, PhD° Sharon Beyer Shruti Bhatt, PhD° Big Foot Lions Club Lia and Brett Bishop Julie Bitner Jessica Bles Terri Bobek Beth Boehland Michele Bogacki Brenda Bogue John and Kathie Bollero Rian Bolte
Mark Heffernan Dave Henderson Linda Hendrickson Pat and Dale Herman Jennifer Heston Deb and Dan Hoadley Emma Hobday Sarah Holden Laura Holliday Andrew Hong, MD° Terri Hooker Peggy Hopkins Tammy Houk Mandy Huff Christi and Byron Hunter
Chris Huston Jay Ieronimo Joanne Jahnke Robin Jeffers Aaron and Darcy Jesser+ Charles and Barbara Jesser, CPA Florence Jesser and Family Larry Johnson William and Helen Johnson* Patrick Joyce Kristine Jurczyk Susan Kaech, PhD° Jody and Bill Kalma+ Elaine Kanelos Jason Katz Roberta Katz Barb Kaufman Maureen Kaufman Gregory Kearney Irene Keeley and Charles Chalko Joseph Kelly+ Wendy Kennedy+
Sue Bongiovanni Michael Bourke Jane Bradford Ellen Brenner Tom Brinegar
The Brunk Foundation Anne Brunk Peterson* Kirsten Bryant, PhD° Patricia Buchholtz Deborah Buckley Kelly Buckley
Fireman Dan Pitt+ Debra Fitzgerald+ Alyssa Fitzpatrick Austen Forbeck Jennifer Forbeck Patricia Forbeck* Anne Forman Lindsey Foster Jaclyn Fowler Linda Frame Kristina Frankel Christina Fritts Pam Fuller Cathy Funderburg Billy and Rachel Gage Maggie Gage*
Deb Burmeister Stephanie Busby Laura Calabrese Annie Calteaux+ Michael Caputo Charles and Linda Carey Norman and Liz Cavedo, Jr Robert Ceddia Celebration on Wells^ Bruce, MD, and Davi Chabner° Stephen Chanock, MD° Chef Abel Rosas, Elena Catering^ Dr. Clark Chen, MD, PhD° Edward B. Chez Susie Claffy Jeannine Clark Lisa Clucas Katie Coates
Lisa Metcalf Amy Meyer Mia Faccia
Becky Millar Donna Miller Kate Miller+ Ron and Lauren Miller*+
Hannah Kight Carol Kinzer+ William Kinzer* James Kirchschlager Lauren Kjome George Klug Wayne and Nan Kocourek Foundation Jackson Koller
Jessica Milnes Sarah Mitchiner Patricia Moll Pamela Monaco Lara Moore Patricia Moore Rob Moore and Kristie St. Pierre+
Ally M. Gambino Hanna Gambino
Matt and Lisa Garrison Nancy Geldermann*+ Matthew Gerdes
° SCIENTIFIC CIRCLE | * SCHOLAR SPONSOR | ^ EVENT SPONSOR | + VOLUNTEER
14
Dr. Raul Mostoslavsky, MD, PhD° Renee Mulder Lexi Muller Chuck J. Myers Terisa and John Namy+ Nina Nicosia Jenny Nikaido Molly Nitka Steve and Mary O`Connor Carlo Obligato Brenda and Greg O’Brien+ Michael Obrochta Mary Odoherty John O’Neill*+ Patrick and Melinda O’Neill* Debra Otlewis Otzen Family Foundation Angela Overstreet Lisa Pabst
Mary Reed Thomas Reed^ Joseph Reina Natalie and Mark Reno James V Riley Tom and Maria Rill Meghan Rill Mary Kay Ring Mollie Ring John and Elizabeth Ring Kurt and Brenda Ripkey
Grace Shields Erin Shipton Olivia Shorter Michael Siavelis Michelle Silberfine Stuart and Linda Silver Mary Sivik Adam and Lisa Smith Jacquelyn Smith Jennifer Smith Patricia Lynn Smith Tom Soha Leo and Stephanie Somerville Matt Soucek The Spedale Family*
Therese Turnbaugh John Vaile Jo Ellen and Jim Vanek* Siva Karthik Varanasi, PhD° Howard Vaughan III Kirsten Vermulen Andrea Viarrial-Murphy Patricia Vlasak Samuel Volchenboum, MD, PhD°
Vosges Haut-Chocolat^ Nikki and Shawn Waller
Lauren Roadman+ Wendy Robbins+ Charles Roberts, MD, PhD° Lisa Robison Michelle and Kevin Roblee Daniela Robles-Espinoza, PhD° Andrea and Cordell Roebker+ Matthew Roesner David and Paula Rogers Diane Rogge
Marla Walsh Karen Warner Lisa Warren Lisa and Mike Weiler Jessica Welser Pam and Ray Wenc*+ Maureen Wheeler Catherine and Ken Williams Nancy Williams Mara Willner Jeannette Windon Robert and Allison Windon+ Wolf Living Trust Roland Wolff Kris Cameron Wood, PhD° Angela Woodward and Steve Green Dave and Susan Wright Guang Yao, PhD° Sheri Young Susan Ziganto Steven and Berta Zorich
Joe Spinasanto Joan Stafslien Anthony Stallone Holly Starck* Jeffrey Steinberg Ed Stites, MD, PhD°
Lea Pacocha Bonnie Parille Jeanette Parker Ravi Patel, MD, PhD°* Vicki Pauly Michele Perlis Nancy Perry Lawrence Pfeil Richard and Mary Jo Pfeil
Joelle Rohleder Dana Rolander Frank and Joni Roman+
Dave Hammerl Courtany Stoner Cathy Stoodley Sub-Zero Candy^ Lisa Sudmeier, MD, PhD° Michelle Sugerman Zach Sutter Alejandro Sweet-Cordero, MD° Stephanie Syner Jeff Tansing Bob Tantillo Alexa Taylor Aaron and Chrissy Taylor Julie and Tom Tefft* Summer Tessem Karin Bennett Emma Thomas Timothy and Wendy Tobin Stephen and Susan Tolbert Linda Tonge Edward Tucker
Gianna Romano Lindsey Roskoph Tara Ross Nicole and Bryant Rowean Lorie Rubio Adrian and Catherine Sakowicz Barbara Sander Melodi Sapyta John and Laura Schanz Laura Schiavoni and Brian Willard*+
Megan Phillips Frankie Pinello Miranda Porterfield Greg Posterities Raeba Pradhan Kim Preacott
Luis Prieto, PhD° Elizabeth Prutch Pamela Przybyla Gary G and Cynthia J Quinn Trust Eddie Raniere Kimryn Rathmell, MD, PhD and Jeffrey Rathmell, PhD° Emily Raub
Amy Schiller Brad Schmidt Suzie Schreier Bob Sr. and Becky Schutz Amanda Shaker Cindy Shanahan Margaret Shaughnessy* Kelli Sheppe
IN HONOR OF
IN MEMORY OF
The Bartels Family Ben Collins and Family
Billy Guy Forbeck David Bruce Collins George Forbeck Kevin Patrick Forbeck Jane Frackelton William H. Frackelton William H. Frackelton II Stephen Gistenson Margaret Heibing Dan Huber Frederick Kees Mary Ann Kirchschlager Jean McKee Barry
Richard “Dickie” Payne Mary Ellen Phillips
Dorcas Collins Jamie Collins Christine Crum
Pilar C Reyes Richard Ring
Mark Rosenbaum Tommy Smothers Norine C Smyth Kira Faith Spedale
Jennifer Forbeck Forbeck Scholars Byron Hunter Charles H Jesser, CPA Howard Katz Ann Lehman and Corado Cipria Kelly Millar Melinda and Patrick O’Neill Howard and JoAnn Wright
LEINEBERG FOUNDATION
Lake Geneva O U T D O O R S
Glenn Neff Tom O’Neill
15
P.O. BOX 1033 CARBONDALE, COLORADO 81623
“Thank you again for thinking of me to attend the meeting and for organizing such a stimulating and well-run Forum. As a biochemist who works quite far from the clinical side of things, I found the discussions eye-opening and learned a great deal. It was a real privilege to engage with such a dynamic and thoughtful group. I share your hope that the connections made at Forbeck will grow into fruitful collaborations. The format was incredibly effective in sparking new ideas and fostering genuine dialogue.” Siavash Vahidi, PhD • Assistant Professor • Department of Molecular and Cellular Biology • University of Guelph
WAYS TO GIVE TO THE FOUNDATION: 1. Make a donation - Your gift supports scientific research. Donate one-time or set up a recurring monthly donation. Simply use the QR code to the left. 2. Sponsor a Scholar - Invest in the future of science with a $1,000 annual contribution for three years ($3,000 total). Scholars gain collaboration opportunities, including attendance at Forbeck Forums and Scholar Retreats. 3. Sponsor a Forum - Become a title sponsor for a 2026 Forum, covering diverse cancer types. Title sponsorship is $40,000. 4. Sponsor a Fundraiser - Help make our upcoming events a success! Explore our event lineup at forbeckfoundation.org/events.
CONTRIBUTIONS ARE TAX DEDUCTIBLE FOR FEDERAL IRS PURPOSES. IRS FILE NUMBER: 580063499
Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16Made with FlippingBook. PDF to flipbook with ease